NM_001099922.3:c.2573A>G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001099922.3(ALG13):​c.2573A>G​(p.Asn858Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000265 in 1,209,200 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N858D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000028 ( 0 hom. 5 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.645

Publications

1 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015950978).
BP6
Variant X-111736757-A-G is Benign according to our data. Variant chrX-111736757-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 238292.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.0000283 (31/1097206) while in subpopulation AMR AF = 0.000797 (28/35130). AF 95% confidence interval is 0.000566. There are 0 homozygotes in GnomAdExome4. There are 5 alleles in the male GnomAdExome4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001099922.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
NM_001099922.3
MANE Select
c.2573A>Gp.Asn858Ser
missense
Exon 23 of 27NP_001093392.1
ALG13
NM_001257231.2
c.2339A>Gp.Asn780Ser
missense
Exon 23 of 27NP_001244160.1
ALG13
NM_001324292.2
c.2573A>Gp.Asn858Ser
missense
Exon 23 of 26NP_001311221.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
ENST00000394780.8
TSL:2 MANE Select
c.2573A>Gp.Asn858Ser
missense
Exon 23 of 27ENSP00000378260.3
ALG13
ENST00000927365.1
c.2549A>Gp.Asn850Ser
missense
Exon 23 of 27ENSP00000597424.1
ALG13
ENST00000927366.1
c.2399A>Gp.Asn800Ser
missense
Exon 21 of 25ENSP00000597425.1

Frequencies

GnomAD3 genomes
AF:
0.00000893
AC:
1
AN:
111994
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000948
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000124
AC:
22
AN:
177333
AF XY:
0.0000460
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000816
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000283
AC:
31
AN:
1097206
Hom.:
0
Cov.:
29
AF XY:
0.0000138
AC XY:
5
AN XY:
362742
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26368
American (AMR)
AF:
0.000797
AC:
28
AN:
35130
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19353
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30161
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53984
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
841522
Other (OTH)
AF:
0.0000652
AC:
3
AN:
46047
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000893
AC:
1
AN:
111994
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34158
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30787
American (AMR)
AF:
0.0000948
AC:
1
AN:
10552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2693
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6084
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53234
Other (OTH)
AF:
0.00
AC:
0
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000181
ExAC
AF:
0.0000830
AC:
10

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 36 (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
6.1
DANN
Benign
0.58
DEOGEN2
Benign
0.18
T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.61
T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L
PhyloP100
0.65
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.011
Sift
Benign
0.49
T
Sift4G
Benign
0.85
T
Polyphen
0.031
B
Vest4
0.047
MutPred
0.22
Loss of catalytic residue at N858 (P = 0.0139)
MVP
0.65
MPC
0.14
ClinPred
0.022
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.043
gMVP
0.11
Mutation Taster
=98/2
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs756238772; hg19: chrX-110979985; API